| Summary of results A: pain‐free and headache relief | |||||||
| Studies |
Attacks treated |
Treatment (%) |
Placebo or comparator (%) |
Relative benefit (95% CI) |
NNT (95% CI) |
P for difference | |
| Pain‐free at 2 hours | |||||||
| Zolmitriptan 1 mg (all formulations) versus placebo | 4 | 1200 | 22 | 8 | 2.7 (2.0 to 3.7) | 7.1 (5.5 to 9.9) | |
| Zolmitriptan 1 mg oral versus placebo | 3 | 384 | 15 | 8 | 1.9 (1.1 to 3.3) | 14 (7.4 to 170) | 1 mg oral vs 2.5 mg oral z = 3.933, P = 0.001 |
| Zolmitriptan 2.5 mg (all formulations) versus placebo | 12 | 5825 | 30 | 10 | 3.0 (2.6 to 3.5) | 5.1 (4.7 to 5.7) | |
| Zolmitriptan 2.5 mg oral versus placebo | 11 | 5223 | 30 | 10 | 3.0 (2.6 to 3.5) | 5.0 (4.5 to 5.6) | |
| Zolmitriptan 5 mg (all formulations) versus placebo | 11 | 9372 | 33 | 11 | 3.0 (2.7 to 3.2) | 4.7 (4.4 to 5.1) | |
| Zolmitriptan 5 mg oral versus placebo | 8 | 4277 | 31 | 10 | 3.2 (2.7 to 3.7) | 4.8 (4.3 to 5.4) | 5 mg oral versus 5 mg nasal z = 0.53, P = 0.10 |
| Zolmitriptan 5 mg nasal spray versus placebo | 3 | 5095 | 34 | 12 | 2.8 (2.5 to 3.2) | 4.6 (4.2 to 5.2) | |
| Zolmitriptan 10 mg oral versus placebo | 2 | 648 | 37 | 5 | 7.8 (4.2 to 14) | 3.1 (2.7 to 3.7) | 10 mg oral versus 5 mg oral z = 3.882, P = 0.0001 |
| Headache relief at 2 hours | |||||||
| Zolmitriptan 1 mg (all formulations) versus placebo | 4 | 861 | 55 | 31 | 1.8 (1.5 to 2.1) | 4.3 (3.3 to 5.9) | |
| Zolmitriptan 1 mg oral versus placebo | 3 | 399 | 50 | 32 | 1.6 (1.2 to 2.0) | 5.6 (3.7 to 12) | 1 mg oral versus 2.5 mg oral z = 2.657, P = 0.008 |
| Zolmitriptan 2.5 mg (all formulations) versus placebo | 11 | 4904 | 60 | 29 | 2.1 (1.9 to 2.2) | 3.3 (3.0 to 3.6) | |
| Zolmitriptan 2.5 mg oral versus placebo | 10 | 4567 | 61 | 29 | 2.1 (1.9 to 2.2) | 3.2 (3.0 to 3.5) | |
| Zolmitriptan 5 mg (all formulations) versus placebo | 11 | 7456 | 63 | 32 | 2.0 (1.9 to 2.1) | 3.2 (3.0 to 3.5) | |
| Zolmitriptan 5 mg oral versus placebo | 8 | 4292 | 59 | 30 | 1.9 (1.8 to 2.1) | 3.5 (3.2 to 3.9) | 5 mg oral versus 5 mg nasal z = 2.746, P = 0.006 |
| Zolmitriptan 5 mg nasal spray versus placebo | 3 | 3164 | 68 | 33 | 2.1 (1.9 to 2.2) | 2.9 (2.6 to 3.2) | |
| Zolmitriptan 10 mg oral versus placebo | 2 | 648 | 69 | 28 | 2.5 (2.0 to 3.1) | 2.4 (2.1 to 3.0) | 10 mg oral versus 5 mg oral z = 2.987, P = 0.003 |
| Zolmitriptan 2.5 mg versus sumatriptan 50 mg (oral) | 2 | 1609 | 66 | 68 | 0.96 (0.90 to 1.0) | not calculated | |
| Zolmitriptan 5 mg versus sumatriptan 50 mg (oral) | 2 | 1633 | 67 | 68 | 0.98 (0.92 to 1.1) | not calculated | |
| Headache relief at 1 hour | |||||||
| Zolmitriptan 5 mg oral versus placebo | 7 | 3584 | 39 | 22 | 1.8 (1.6 to 2.1) | 6.1 (5.2 to 7.5) | 5 mg oral versus 5 mg nasal z = 3.284, P = 0.001 |
| Zolmitriptan 5 mg nasal spray versus placebo | 2 | 2684 | 56 | 32 | 1.8 (1.6 to 1.9) | 4.1 (3.6 to 4.9) | |
| Sustained pain‐free during the 24 hours post dose | |||||||
| Zolmitriptan 2.5 mg oral versus placebo | 2 | 984 | 19 | 6 | 3.5 (2.1 to 5.8) | 7.7 (5.9 to 11) | |
| Zolmitriptan 5 mg (all formulations) versus placebo | 3 | 4991 | 14 | 4 | 4.7 (3.6 to 5.9) | 9.3 (8.1 to 11) | |
| Zolmitriptan 5 mg nasal spray versus placebo | 2 | 4298 | 13 | 3 | 4.9 (3.7 to 6.5) | 9.6 (8.3 to 11) | |
| Sustained headache relief during the 24 hours post dose | |||||||
| Zolmitriptan 2.5 mg (all formulations) versus placebo | 4 | 2059 | 39 | 14 | 2.9 (2.4 to 3.6) | 4.0 (3.5 to 4.7) | |
| Zolmitriptan 2.5 mg oral versus placebo | 4 | 1457 | 38 | 14 | 2.9 (2.2 to 3.7) | 4.1 (3.5 to 5.0) | |
| Zolmitriptan 5 mg (all formulations) versus placebo | 7 | 7106 | 37 | 12 | 3.2 (2.9 to 3.5) | 3.9 (3.6 to 4.2) | |
| Zolmitriptan 5 mg oral versus placebo | 5 | 2827 | 37 | 15 | 2.4 (2.0 to 2.8) | 4.6 (4.0 to 5.3) | 5 mg oral versus 5 mg nasal z = 2.076, P = 0.038 |
| Zolmitriptan 5 mg nasal spray versus placebo | 2 | 4279 | 38 | 9 | 4.0 (3.4 to 4.6) | 3.6 (3.3 to 3.9) | |